Mirum plans USD 600 million convertible senior notes offering due 2032

Mirum Pharmaceuticals

Mirum Pharmaceuticals

MIRM

0.00
  • Mirum Pharmaceuticals launched a private offering of USD 600 million of convertible senior notes due 2032, with an option for initial purchasers to buy up to an additional USD 90 million.
  • Total potential issuance size of up to USD 690 million.
  • Proceeds earmarked in part to fund privately negotiated exchanges of its outstanding 4.00% convertible senior notes due 2029, with remaining proceeds for general corporate purposes.
  • Holders exchanging 2029 notes may unwind hedges through stock purchases or derivatives, which could move the share price around pricing and affect the effective conversion price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-228902), on May 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.